header image

R&D Recombinant

Octapharma's R&D Recombinant Group is dedicated to:

 

  • The development of therapeutic human recombinant products
  • Clinical upscale and pharmaceutical scale production

 

Recombinant proteins are produced in cultured human cells. Human recombinant proteins produced in human cell lines show identical properties to the same protein derived directly from human tissues and blood. They are therefore expected to show improved tolerance in patients compared to currently available hamster cell-derived recombinant products.

 

The R&D Recombinant Group comprises: